Deep Track Capital, LP 13D and 13G filings for Nurix Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:31 pm Purchase |
2025-02-07 | 13G | Nurix Therapeutics, Inc. NRIX |
Deep Track Capital, LP | 4,125,000 5.440% |
1,125,000 (+37.50%) |
Filing |
| 2025-02-14 08:42 am Purchase |
2024-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Deep Track Capital, LP | 3,000,000 4.240% |
2,170 (+0.07%) |
Filing |
| 2024-02-14 08:51 am Purchase |
2023-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Deep Track Capital, LP | 2,997,830 6.180% |
280,659 (+10.33%) |
Filing |
| 2023-02-24 4:13 pm Purchase |
2023-02-16 | 13G | Nurix Therapeutics, Inc. NRIX |
Deep Track Capital, LP | 2,717,171 5.750% |
450,602 (+19.88%) |
Filing |
| 2023-02-14 08:50 am Sale |
2022-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Deep Track Capital, LP | 2,266,569 4.810% |
-169,595 (-6.96%) |
Filing |
| 2022-06-10 4:02 pm Purchase |
2022-06-01 | 13G | Nurix Therapeutics, Inc. NRIX |
Deep Track Capital, LP | 2,436,164 5.190% |
2,436,164 (New Position) |
Filing |